Catalent Invests $7.3 Million at its Aprilia, Italy Facility Expands Softgel Encapsulation and Packaging Capabilities in Support of Consumer Health and Beauty Growth SOMERSET, N.J., October 4, 2018 – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it had […]
Read MoreCategory: blog
Tioga Research is excited to announce that it has been named a Scrip Award finalist in the Best CRO – Specialist Providers category. The Scrip Award highlights the highest achievers of innovation in the biotechnology and pharmaceutical industries.
Tioga Research is excited to announce that it has been named a Scrip Award finalist in the Best CRO – Specialist Providers category. The Scrip Award highlights the highest achievers of innovation in the biotechnology and pharmaceutical industries. For more information, please click on the link below. https://pharmaintelligence.informa.com/events/awards/scrip-awards-2018/shortlist Tioga Research
Read MoreCatalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies
Catalent Selected to Provide Oral Delivery Systems for GB Sciences’ Proprietary Parkinson’s Disease Therapies GB Sciences and Catalent tackle the first-ever formulations of APIs containing up to nine cannabinoids and terpenoids for the treatment of Parkinson’s disease SWINDON, U.K., and LAS VEGAS, September 26, 2018– GB Sciences, Inc. (OTCQB: GBLX) and Catalent Pharma Solutions, the […]
Read MoreTioga Research at the first Annual San Diego Futures Foundation STEMFEST. They had the opportunity to educate the community on skin permeation and various forms of skin applied formulations.
Ashley and Holly represented Tioga Research at the first Annual San Diego Futures Foundation STEMFEST. They had the opportunity to educate the community on skin permeation and various forms of skin applied formulations. Tioga Research
Read MoreAucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form
Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent for Vigabatrin Stick Pack Dosage Form Catalent Somerset, N.J. – September 4, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a commercial supply agreement for Aucta Pharmaceuticals, Inc.’s (Aucta) vigabatrin. […]
Read MoreSherpa Clinical Packaging and De:terminence Announce Initiative to Help Rare Disease Patients Climb Mountains
Sherpa Clinical Packaging and De:terminence Announce Initiative to Help Rare Disease Patients Climb Mountains Sherpa Clinical Packaging Partnership will Raise Funds Dedicated to Purchasing Equipment and Training Programs for Rare Disease Patients Sacramento and San Diego, CA, August 21, 2018 — Sherpa Clinical Packaging and De:terminence are pleased to announce a joint fundraiser to […]
Read MoreOrthotopic PDX Models with Quantitative Pathology End Points Provide a New Standard in Translational Oncology Drug Development
Orthotopic PDX Models with Quantitative Pathology End Points Provide a New Standard in Translational Oncology Drug Development Reveal Biosciences Orthotopic Patient-Derived Xenografts (PDX) Despite the rise of personalized approaches to the treatment of cancer, translating these therapies into a clinical setting still poses an exceptional challenge. This is highlighted in drug development where research […]
Read More